HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Suppression of Aggrus/podoplanin-induced platelet aggregation and pulmonary metastasis by a single-chain antibody variable region fragment.

Abstract
Almost all highly metastatic tumor cells possess high platelet aggregating abilities, thereby form large tumor cell-platelet aggregates in the microvasculature. Embolization of tumor cells in the microvasculature is considered to be the first step in metastasis to distant organs. We previously identified the platelet aggregation-inducing factor expressed on the surfaces of highly metastatic tumor cells and named as Aggrus. Aggrus was observed to be identical to the marker protein podoplanin (alternative names, T1α, OTS-8, and others). Aggrus is frequently overexpressed in several types of tumors and enhances platelet aggregation by interacting with the platelet receptor C-type lectin-like receptor 2 (CLEC-2). Here, we generated a novel single-chain antibody variable region fragment (scFv) by linking the variable regions of heavy and light chains of the neutralizing anti-human Aggrus monoclonal antibody MS-1 with a flexible peptide linker. Unfortunately, the generated KM10 scFv failed to suppress Aggrus-induced platelet aggregation in vitro. Therefore, we performed phage display screening and finally obtained a high-affinity scFv, K-11. K-11 scFv was able to suppress Aggrus-induced platelet aggregation in vitro. Moreover, K-11 scFv prevented the formation of pulmonary metastasis in vivo. These results suggest that K-11 scFv may be useful as metastasis inhibitory scFv and is expected to aid in the development of preclinical and clinical examinations of Aggrus-targeted cancer therapies.
AuthorsKenichi Miyata, Satoshi Takagi, Shigeo Sato, Hiroshi Morioka, Kiyotaka Shiba, Tamiko Minamisawa, Miho Takami, Naoya Fujita
JournalCancer medicine (Cancer Med) Vol. 3 Issue 6 Pg. 1595-604 (Dec 2014) ISSN: 2045-7634 [Electronic] United States
PMID25132683 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2014 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
Chemical References
  • Antibodies, Monoclonal, Murine-Derived
  • Membrane Glycoproteins
  • Membrane Proteins
  • PDPN protein, human
  • Single-Chain Antibodies
Topics
  • Animals
  • Antibodies, Monoclonal, Murine-Derived (immunology, pharmacology)
  • CHO Cells
  • Cell Line, Tumor
  • Cricetinae
  • Cricetulus
  • Female
  • Humans
  • Lung Neoplasms (blood, pathology, secondary, therapy)
  • Membrane Glycoproteins (antagonists & inhibitors, blood, immunology)
  • Membrane Proteins (antagonists & inhibitors, blood, immunology)
  • Mice, Inbred BALB C
  • Mice, Nude
  • Neoplasm Metastasis
  • Platelet Aggregation (drug effects)
  • Rabbits
  • Single-Chain Antibodies (immunology, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: